Assyro AI

Orange Book product · Generic (ANDA)

SODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDE

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

Generic (ANDA)ANDA 216095TE ABRX LUPIN

At a glance

May 28, 2026

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 28, 2026

    22 d ago

  2. Today

Pharmaceutical detail

Active ingredient

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

Strength

0.225GM;0.188GM;1.479GM

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 216095

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.